HC Deb 02 March 2004 vol 418 c816W
Mr. Laws

To ask the Chancellor of the Exchequer what his estimate is of the cost to public expenditure of each company tax credit for each year from 2003–04 to 2006–07; and if he will make a statement. [156765]

Dawn Primarolo

The forecast costs for research and development tax credits, vaccines research relief and contaminated land tax credits are set out in the following table. The costs are on a receipts basis, showing when the costs are incurred by the Inland Revenue.

£ million
2003–04 2004–05 2005–06 2006–07
Research and Development Tax Credits 660 670 700 760
Vaccines Research Relief 10 20 20 20
Contaminated Land Tax Credits 70 80 80 90
Note:
Figures are rounded to the nearest £10 million.

Mr. Laws

To ask the Chancellor of the Exchequer if he will list each tax credit available to companies; what assessment he has made of the economic benefit in each case; and if he will make a statement. [156766]

Dawn Primarolo

Companies may be able to claim tax credits under the research and development tax credit schemes, vaccines research relief scheme or remediation of contaminated land scheme.

The Government plan to evaluate all of the impacts of these policies. However, because the policies are intended to produce benefits over the medium to longer term, it would be inappropriate to do so at present.

Forward to